Interferons dominate damage and activity in juvenile scleroderma

Area of Science:

• Immunology
• Pediatric Rheumatology
• Dermatology

Background:

• Juvenile scleroderma encompasses juvenile localized scleroderma and juvenile systemic sclerosis, characterized by skin lesions.
• Interferon (IFN) signaling pathways are implicated in autoimmune and fibrotic processes.

Purpose of the Study:

• To quantify cytokine and chemokine levels within the IFN signaling pathway in juvenile scleroderma patients.
• To correlate these levels with disease severity and activity.

Main Methods:

• ELISA and RT-PCR were used to measure 10 cytokines/chemokines and 7 IFN-stimulated genes (ISGs).
• Study included 29 juvenile localized scleroderma, 5 juvenile systemic sclerosis patients, and 9 healthy controls.

Main Results:

• Elevated levels of IFN-α, IFN-β, IFN-γ, TNF-α, IL-1, IL-6, IL-8, IP-10, and MCP1 were found in juvenile systemic sclerosis compared to controls.
• IFN-α and IP-10 were elevated in both juvenile localized scleroderma and juvenile systemic sclerosis.
• Active disease showed significantly higher levels of IFN-β, IFN-γ, TNF-α, IL-8, IP10, MCP1, and CXCL11 compared to inactive disease.

Conclusions:

• IFN signaling pathways are likely dysregulated in juvenile scleroderma.
• Cytokine and gene expression changes offer potential for monitoring disease activity.
• IFN-α and IFN-γ may serve as valuable biomarkers for assessing juvenile scleroderma activity and damage.